1 Jobs found

Context Nuclear medicine has evolved considerably over recent years with the emergence of radiotheranostics, a modality which combines targeted diagnosis and therapy with radioisotopes. It offers an important and promising alternative in the treatment of many cancers. Radiotheranostics is based on the use of radioisotopes which, when they decay, emit radiation that enables cancer cells to be precisely located and/or destroyed. Among these radioisotopes, one of the most promising therapeutic is the alpha-emitting Actinium-225. One of the main challenges to making this therapeutic solution accessible for the greatest number of patients is ensuring the availability of high-quality Actinium-225 in large quantities. It is often referred within the community as “the rarest drug on Earth”. By joi...